Skip to content
  • Brands
  • Investor Centre
  • Contact

East Coast Research: Analyst Upgrades Target Price to .017

UncategorizedBy Matthew ReedeJuly 4, 2024Leave a comment

The Australian: Wellness Stocks Offering Calm and Relief

UncategorizedBy Matthew ReedeJune 21, 2024Leave a comment

Stockhead: ASX Wellness Stocks Offering Calm and Relief

UncategorizedBy Matthew ReedeJune 21, 2024Leave a comment

Sydney Morning Herald: Wellness Company Delivers Nerve Calming Goods

UncategorizedBy Matthew ReedeJune 7, 2024Leave a comment

The Market Online: The Calmer Co Sees Shares Rise 83% on News of Record Online Sales for May

UncategorizedBy Matthew ReedeJune 5, 2024Leave a comment

Stockhead: The Calmer Co Jumps 100% on Strong Momentum in May

UncategorizedBy Matthew ReedeJune 5, 2024Leave a comment

Stockhead: Long Shortz with The Calmer Co: Chillin’ out whilst crushing sales in kava

UncategorizedBy Matthew ReedeMay 23, 2024Leave a comment

Stockhead TV Stockhead TV

Stockhead: Kava sales boom as global growth continues for The Calmer Co

UncategorizedBy Matthew ReedeMay 16, 2024Leave a comment

Market Open: Calmer Co clocks $150K in sales of its kava-based health drinks at Coles

UncategorizedBy Matthew ReedeMay 15, 2024Leave a comment

Stockhead: Online sales of Calmer Co wellness products surpasses 10k per day for March

UncategorizedBy Matthew ReedeApril 4, 2024Leave a comment
←123→

The Calmer Co.
(ASX:CCO)

Join our Mailing List

Useful Links

  • Investor Centre
  • Terms and Conditions
  • Privacy Policy

Contact Information

+61 429 210 031

investors@thecalmerco.com

Brisbane QLD 4101, Australia

© 2023 The Calmer Co. International Limited All Rights Reserved.
Go to Top